10 completed, 1 terminated, 1 unknown. 12 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Completed 10, Terminated 1, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow Placebo powder: new trials by email Literature Review of Placebo powder trials Research Report on Placebo powder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessing the Effect of a Mineral-enriched Powder on Iron Deficiency in Women of Reproductive Age Mineral-enriched powder, Placebo powder - Iron Deficiency, Iron Deficiency Anaemia | Phase 2 | Completed | Carleton University | 150 | 2023-04-27 | 2026-04-27 |
| Effect of Akkermansia Muciniphila WST01 Strain in Overweight or Obese Patients With Type 2 Diabetes WST01 strain product, placebo powder - Obese, Overweight | Phase 2 | Unknown | Shanghai Jiao Tong University School of Medicine | 60 | 2021-07-15 | 2023-10-17 |
| Wild Blueberries and Cardiovascular Health in Middle-aged/Older Men and Postmenopausal Women Blueberry Powder, Placebo Powder - Hypertension, Aging | Phase 1 / Phase 2 | Completed | Colorado State University | 60 | 2020-01-01 | 2026-10-30 |
| Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy AR201 powder, Placebo powder - Hen Egg Allergy | Phase 2 | Terminated | Aimmune Therapeutics, Inc. | 15 | 2019-08-20 | 2022-03-10 |
| CoQ10 and D-ribose in Patients With Diastolic Heart Failure CoQ10, D-Ribose Oral Powder, Placebo pills - Heart Failure, Diastolic | Phase 2 | Completed | University of Kansas Medical Center | 216 | 2018-02-05 | 2022-03-18 |
| Impact of Grape Consumption on Brain Metabolism and Neuropsychological Performance Over 1 Year Grape Powder, Placebo Powder - Mild Cognitive Impairment | Phase 2 | Completed | University of California, Los Angeles | 32 | 2017-11-18 | 2023-02-21 |
| A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis X0002, Placebo - Osteoarthritis of the Knee | Phase 2 | Completed | Lina Xu | 216 | 2014-02-01 | 2018-02-07 |
| Phenylbutyrate Therapy for Maple Syrup Urine Disease Phenylbutyrate, Placebo powder - Maple Syrup Urine Disease | Phase 2 / Phase 3 | Completed | Brendan Lee | 20 | 2013-02-01 | 2019-03-19 |
| D-Ribose for Fatigue in Subjects With Fibromyalgia D-Ribose Powder, Placebo Powder - Fibromyalgia | Phase 2 | Completed | RiboCor, Inc. | 110 | 2011-05-01 | 2013-09-18 |
| A Human Trial to Evaluate the Efficacy and Safety of Aged Garlic Powder on Improvement of Blood Lipids in Subjects With Hyperlipidemia Aged garlic powder, Placebo powder - Hyperlipidemia | Phase 2 / Phase 3 | Completed | Chonbuk National University Hospital | 60 | 2010-07-01 | 2012-10-12 |
| A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy Peanut powder, Peanut extract, Placebo extract - Peanut Hypersensitivity, Food Hypersensitivity | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 21 | 2010-03-01 | 2017-04-07 |
| Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI Lym-X-Sorb powder, Placebo powder - Cystic Fibrosis, Pancreatic Insufficiency | Phase 2 | Completed | Avanti Polar Lipids, Inc. | 110 | 2007-01-01 | 2013-01-14 |
Food Hypersensitivity (2) · Alzheimer Disease (1) · Anemia, Iron-Deficiency (1) · Atherosclerosis (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cognitive Dysfunction (1) · Cystic Fibrosis (1) · Dementia (1) · Diabetes Mellitus, Type 2 (1) · Exocrine Pancreatic Insufficiency (1) · Fatigue (1) · Fibromyalgia (1) · Heart Failure, Diastolic (1)
Aimmune Therapeutics, Inc. (1) · Avanti Polar Lipids, Inc. (1) · Brendan Lee (1) · Carleton University (1) · Chonbuk National University Hospital (1) · Colorado State University (1) · Johns Hopkins University (1) · Lina Xu (1) · RiboCor, Inc. (1) · Shanghai Jiao Tong University School of Medicine (1) · University of California, Los Angeles (1) · University of Kansas Medical Center (1)
United States (9) · Canada (1) · China (1) · South Korea (1)
Brendan Lee, M.D., Ph.D. (1) · Chongxi Yu, Ph.D. (1) · Dal-Sik Kim, MD (1) · Daniel H Silverman, MD, PhD (1) · Janet Pierce, PhD (1) · Kristin Connor, PhD (1) · Leslie Crofford, MD (1) · Robert Wood, MD (1) · Virginia A. Stallings, MD (1) · Walter A. Shaw, PhD (1)
PMID 24345827, PMID 24518280, PMID 25528358, PMID 25578927, PMID 26465792, PMID 27050056, PMID 29606104, PMID 32384122, PMID 35644694, PMID 37671264, PMID 39879980
R01AG054486 (1), R44DK060302 (1)